Amgen
biotechnology company
Amgen Inc.. The Group’s principal activities are to discover, develop, manufacture and market human therapeutics based on advances in cellular and molecular biology. It markets human therapeutic products in the areas of hematology, oncology...Founded in 1985
Homepage: http://www.amgen.com
HQ
91320-1799 One Amgen Center DriveThousand Oaks
USA CA
Phone: +1 805-447-1000
Updated on Apr 10, 2012
Amgen at CrunchBase
Anne Dixon Amgen at CrunchBase
Joe Sandoval Business Planning Analyst
Past
Mooky Desai Technology Consultant
Heather Franklin Sr. Research Operations Program Manager
Jim Haughwout
May, 2012
Amgen invested $10M in Gamida Cell as a Series E round
April, 2012
Amgen acquired KAI Pharmaceuticals for $315M
UPDATED: Amgen snags KAI Pharma's CKD program in $315M buyout 
fiercebiotech.com
January, 2011
Amgen acquired BioVex for $1B
BioVex to be acquired by Amgen for up to $1 billion 
masshightech.com
Amgen, has reached agreement to acquire BioVex Group Inc. for what could total $1 billion
BioVex to be acquired by Amgen for up to $1 billion masshightech.com
November, 2010
Amgen pays Nektar $50M for polymer fiercebiotech.com
October, 2008
Amgen acquired Avidia for $380M
Amgen to buy inflammation drug co. Avidia for up to $380M 
deals.venturebeat.com
June, 2007
Amgen acquired Ilypsa for $420M
Amgen buys kidney-disease biotech Ilypsa for $420M 
venturebeat.com
1985
Amgen was founded in 1985